High Potent Containment Provider ONFAB Enters USA Market
ONFAB, a leading European provider of single-use, flexible containment solutions for the pharmaceutical industry, has officially launched business operations in the United States in conjunction with parent company Savillex. The company’s American hub will be located within the Savillex headquarters in Eden Prairie,…
Venus Remedies awarded its first incentive of Rs.7.50 cr. under PLI scheme
Venus Remedies Ltd, one of India’s leading manufacturers of generic drugs, has been awarded its first disbursement of Rs 7.5 crore under the Central government’s Production Linked Incentive (PLI) scheme for the financial year 2022-23, which covers 75% of the…
Empower Pharma to Purchase Eugia Manufacturing Facility in New Jersey for Large Scale Expansion of Personalized Compounded Medicine
Empower Clinic Services New Jersey LLC DBA Empower Pharma today announced an agreement to purchase a facility in East Windsor, New Jersey from Eugia US Manufacturing LLC (wholly owned subsidiary of Aurobindo Pharma Ltd) and enter into a contract manufacturing relationship. In…
Venus Remedies gets coveted GMP certification from Libya
Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in…
Venus Remedies gets coveted GMP certification from Libya
Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in…
Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency
Veeva Systems (NYSE: VEEV) today announced that SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co. Ltd., a global biotech company, is using Veeva Vault Validation Management to streamline and accelerate their validation process. By adopting a validation solution with built-in best practices,…
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio
On the morning of January 3, Kexing Biopharm signed an international commercialization cooperation agreement on Eribulin Mesylate Injection, securing exclusive commercialization licensing and supply of the product from Xiling Lab Co., Ltd. in 36 countries. This is the fifth major breast cancer…
Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2023 on Wednesday, November 8, 2023, after the market closes. Vanda will host a conference call at 4:30 PM ET on Wednesday, November 8, 2023, during…
Rajiv Malik to Retire as President of Viatris Effective April 1, 2024
Viatris Inc. (NASDAQ: VTRS), a global healthcare company, announced today that its President, Rajiv Malik, will be retiring as an executive of the Company effective April 1, 2024. Malik is a nearly 40-year pharmaceutical industry veteran who has been responsible for the day-to-day…
Pharmaceuticals and Biotechnology Option and Evaluation Deals Report 2023: Comprehensive Details of Actual Deals Signed Since 2016
The “Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2023” report has been added to ResearchAndMarkets.com’s offering. Option and Evaluation Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter option and evaluation deals. Fully revised and…
